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Background 
Cancer survivorship is a growing global concern and the current aftercare system does not sufficiently meet patients’ 
needs;  patterns of recovery should be considered in order to tailor aftercare appropriately.  
Aims 
Examine trajectories of quality of life (QoL), health status and personal wellbeing in the first two years following 
colorectal surgery.  
Methods 
Cohort study of 872 UK colorectal cancer patients. Questionnaires at baseline (pre-surgery), 3, 9, 15, 24 months. QoL, 
health status, personal wellbeing, physical symptoms, anxiety, depression, self-efficacy, social support, socio-
demographic and clinical/treatment characteristics were examined. Longitudinal analyses assessed change in QoL, 
health and wellbeing over time and predictors of trajectories. 
Results 
Four distinct trajectories (groups) were identified for each outcome measure. Group 1: consistently good QoL 
(31.3%), mild and improving health problems (20.9%), consistently good wellbeing (44.9%). Groups 2 and 3: 
intermediate and changing levels of QoL, health status and personal wellbeing. Group 4: consistently poor QoL (5.3%) 
and health status (7.4%), very poor/declining wellbeing (4.2%). 11.5% were in Group 4 for > 1 of the outcomes. 
Higher pre-surgery depression and lower self-efficacy were significantly associated with poorer trajectories for all 
three outcomes after adjusting for other important predictors including disease characteristics, stoma, anxiety and 
social support. 
Conclusions 
Distinct recovery trajectories following colorectal cancer treatment can be identified with risk factors. Different 
approaches to follow-up care are warranted and these results provide robust data regarding who is likely to need 
more intensive support, which will inform the development of risk-stratified follow-up management tailored to an 
individual’s need.   
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